The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
The Hong Kong Association of the Pharmaceutical Industry (HKAPI) is delighted to be one of the supporting organizations of the hybrid event hosted by InvestHK - “The Journey of Biotech Innovation and Investment in Hong Kong” on 7 July.
The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.
The Affordability Task Force and PPP Task Force co-organized a sharing session for members about Drug Affordability.